NuCana (NCNA) Shares Issued (2017 - 2025)
NuCana's (NCNA) quarterly Shares Issued came in at $25.6 million in Q3 2025, up 303.64% year-on-year from $6.3 million in Q3 2024, and up 745.46% quarter-over-quarter from $3.0 million in Q4 2024.
NuCana (NCNA) Shares Issued (2017 - 2025) Analysis & Trends
NuCana has disclosed Shares Issued across 9 years of filings, most recently posting $25.6 million for Q3 2025.
- Shares Issued for Q3 2025 came in at $25.6 million, up 303.64% year-over-year; the trailing twelve-month figure through Dec 2025 was $35.0 million (up 210.73% YoY), and the FY2025 annual result was $26.6 million, up 138.52% from the prior year.
- Shares Issued came in at $25.6 million for Q3 2025 at NuCana, up from $3.0 million in the prior quarter.
- In the past five years, Shares Issued ranged from a high of $25.6 million in Q3 2025 to a low of -$3723.5 in Q4 2023.
- The 5-year median for Shares Issued is $138415.9 (2021), against an average of $3.7 million.
- Across the five-year window, Shares Issued plunged 99.51% in 2022 and soared 250131.37% in 2024, its largest moves.
- NuCana's Shares Issued stood at $273026.3 in 2021, then slumped by 99.51% to $1341.8 in 2022, then sank by 377.49% to -$3723.5 in 2023, then jumped by 81381.95% to $3.0 million in 2024, then soared by 745.46% to $25.6 million in 2025.
- The last three Shares Issued figures came in at $25.6 million (Q3 2025), $3.0 million (Q4 2024), and $6.3 million (Q3 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | 5.40 Mn |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 27.00 Mn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | 26,927.15 |
| 10 | NuCana | 29.13 Bn | 29.13 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 25.59 Mn |
| Sep 30, 2025 | 25.59 Mn |
| Dec 31, 2024 | 3.03 Mn |
| Dec 31, 2024 | 3.03 Mn |
| Sep 30, 2024 | 6.34 Mn |
| Sep 30, 2024 | 6.34 Mn |
| Jun 30, 2024 | 1.88 Mn |
| Jun 30, 2024 | 1.88 Mn |
| Mar 31, 2024 | 3,805.55 |
| Mar 31, 2024 | 3,805.55 |
| Dec 31, 2023 | -3,723.46 |
| Dec 31, 2023 | -3,723.46 |
| Sep 30, 2023 | 2,533.37 |
| Sep 30, 2023 | 2,533.37 |
| Mar 31, 2023 | 1,215.51 |
| Mar 31, 2023 | 1,215.51 |
| Mar 31, 2022 | 1,341.84 |
| Mar 31, 2022 | 1,341.84 |
| Mar 31, 2021 | 273,026.31 |
| Mar 31, 2021 | 273,026.31 |